Evidence map›Paper›PMID 26280007›Full record

ReviewLiver cancer2014

JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan.

Masatoshi Kudo, Osamu Matsui, Namiki Izumi, Hiroko Iijima, Masumi Kadoya, Yasuharu Imai, Takuji Okusaka, Shiro Miyayama, Kaoru Tsuchiya, Kazuomi Ueshima and 7 more

Registry-linked trialAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Liver cancer, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04414956 (Clinical Usefulness of Combining Biomarkers), which is not on this map. Cited by 318 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
318citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04414956 naunknown statusnot on this mapstarted 2016, after this paper: background citation

Clinical Usefulness of Combining Biomarkers (AFP, AFP-L3, and PIVKA-II) With Abdominal Sonography or Computed Tomography for Early Detection of Hepatocellular Carcinoma

TypeinterventionalSponsorKorea UniversityRan2016 to 2026Enrolled1,418ConditionsLiver Cirrhosis, Hepatocellular Carcinoma, SurveillanceArmsAFP-L3, AFP, PIVKA-II, Sonography, CT
3 · Its place in the literature

Who cites it

318 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. [Guideline for stratified screening and surveillance of primary liver cancer(2020 Edition)].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2021
    Guideline
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

258 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Masatoshi KudoDepartment of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka, Japan.
Osamu MatsuiDepartment of Radiology, Kanazawa University Graduate School of Medical Science, Ishikawa, Japan.
Namiki IzumiDepartment of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan.
Hiroko IijimaDivision of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.
Masumi KadoyaDepartment of Radiology, Shinshu University School of Medicine, Nagano, Japan.
Yasuharu ImaiDepartment of Gastroenterology, Ikeda Municipal Hospital, Osaka, Japan.
Takuji OkusakaDepartment of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Shiro MiyayamaDepartment of Diagnostic Radiology, Fukuiken Saiseikai Hospital, Fukui, Japan.
Kaoru TsuchiyaDepartment of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan.
Kazuomi UeshimaDepartment of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka, Japan.
Atsushi HiraokaDepartment of Gastroenterology, Ehime Prefectural Central Hospital, Ehime, Japan.
Masafumi IkedaDepartment of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Japan.
Sadahisa OgasawaraDepartment of Gastroenterology and Nephrology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Tatsuya YamashitaDepartment of Gastroenterology, Kanazawa University Hospital, Ishikawa, Japan.
Tetsuya MinamiDepartment of Radiology, Kanazawa University Hospital, Ishikawa, Japan.
Koichiro YamakadoDepartment of Interventional Radiology, Mie University School of Medicine, Mie, Japan.
Liver Cancer Study Group of Japan

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma proposed by the Japan Society of Hepatology was updated in June 2014 at a consensus meeting of the Liver Cancer Study Group of Japan. Three important items have been updated: the surveillance and diagnostic algorithm, the treatment algorithm, and the definition of transarterial chemoembolization (TACE) failure/refractoriness. The most important update to the diagnostic algorithm is the inclusion of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging as a first line surveillance/diagnostic tool. Another significant update concerns removal of the term "lipiodol" from the definition of TACE failure/refractoriness.

Indexed as

Clinical practice guidelinesDefinition of transarterial chemoembolization failureHepatocellular carcinomaJapan Society of HepatologyLiver Cancer Study Group of Japan

Identifiers

PMID26280007
PMCPMC4531423

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.